# Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study

Mathieu Uro, Olivier Beauchet, Mehdi Cherif, Alix Graffe, Dan Milea, Cédric Annweiler

► To cite this version:

Mathieu Uro, Olivier Beauchet, Mehdi Cherif, Alix Graffe, Dan Milea, et al. Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study. PLoS ONE, 2015, 10 (6), pp.e0130879. 10.1371/journal.pone.0130879. hal-04642842

HAL Id: hal-04642842

https://hal.science/hal-04642842v1

Submitted on 10 Jul 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

CrossMark
click for updates

<figure><img src="image_3.png" /></figure>

OPEN ACCESS

**Citation:** Uro M, Beauchet O, Cherif M, Graffe A, Milea D, Annweiler C (2015) Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study. PLoS ONE 10(6): e0130879. doi:10.1371/journal.pone.0130879

**Editor:** Friedemann Paul, Charité University Medicine Berlin, GERMANY

**Received:** November 14, 2014

**Accepted:** May 26, 2015

**Published:** June 19, 2015

**Copyright:** © 2015 Uro et al. This is an open access article distributed under the terms of the [Creative Commons Attribution License](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

**Data Availability Statement:** Per the Commission nationale de l'informatique et des libertés (CNIL), patient-level data are freely available from the corresponding author at [CeAnnweiler@chu-angers.fr](mailto:CeAnnweiler@chu-angers.fr). Anonymized raw data are available after notification and authorization of the relevant authorities.

**Funding:** The study was financially supported by the French Ministry of Health (Projet Hospitalier de Recherche Clinique national n°2009-A00533-54). The funder had no role in study design, data

RESEARCH ARTICLE

# Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study

Mathieu Uro¹, Olivier Beauchet², Mehdi Cherif¹, Alix Graffe¹, Dan Milea¹,³,⁴,⁵, Cedric Annweiler²,⁶*

1 Department of Ophthalmology, Angers University Hospital, Angers, France, 2 Department of Neuroscience, Division of Geriatric Medicine, Angers University Hospital, University Memory Clinic of Angers; UPRES EA 4638, University of Angers, UNAM, Angers, France, 3 Singapore National Eye Centre, Singapore, 4 Singapore Eye Research Institute, Singapore, 5 Duke-NUS, Neuroscience and Behavioral Diseases, Singapore, 6 Robarts Research Institute, Department of Medical Biophysics, Schulich School of Medicine and Dentistry, the University of Western Ontario, London, Ontario, Canada

* CeAnnweiler@chu-angers.fr

## Abstract

### Background

Vitamin D deficiency is associated with smaller volume of optic chiasm in older adults, indicating a possible loss of the visual axons and their cellular bodies. Our objective was to determine whether vitamin D deficiency in older adults is associated with reduced thickness of the ganglion cell complex(GCC) and of the retinal nerve fibre layer(RNFL), as measured with high-definition optical coherence tomography(HD-OCT).

### Methods

Eighty-five French older community-dwellers without open-angle glaucoma and patent age-related macular degeneration(mean, 71.1±4.7years; 45.9%female) from the GAIT study were separated into 2 groups according to serum 25OHD level(i.e., deficient≤25nmol/L or sufficient>25nmol/L). Measurements of GCC and RNFL thickness were performed using HD-OCT. Age, gender, body mass index, number of comorbidities, dementia, functional autonomy, intracranial volume, visual acuity, serum calcium concentration and season of testing were considered as potential confounders.

### Results

Mean serum 25OHD concentration was 58.4±26.8nmol/L. Mean logMAR visual acuity was 0.03±0.06. Mean visual field mean deviation was -1.25±2.29dB. Patients with vitamin D deficiency(n=11) had a reduced mean GCC thickness compared to those without vitamin D
collection and analysis, decision to publish, or
preparation of the manuscript.

**Competing Interests:** The authors have declared
that no competing interests exist.

deficiency(72.1±7.4µm versus 77.5±7.5µm, P=0.028). There was no difference of the mean RNFL thickness in these two groups(P=0.133). After adjustment for potential confounders, vitamin D deficiency was associated with reduced GCC thickness(β=-5.12, P=0.048) but not RNFL thickness(β=-9.98, P=0.061). Specifically, vitamin D deficiency correlated with the superior medial GCC area(P=0.017) and superior temporal GCC area(P=0.010).

**Conclusions**

Vitamin D deficiency in older patients is associated with reduced mean GCC thickness, which can represent an early stage of optic nerve damage, prior to RNFL loss.

**Introduction**

Besides its classical function of bone metabolism regulation, vitamin D exhibits multiple bio-
logical targets mediated by its nuclear hormone receptor, the Vitamin D Receptor (VDR) [1,2].
In particular, by binding to the VDRs present in the endothelial retina cells [2,3] and in the
neurons and glial cells of the brain [4], vitamin D influences a number of physiological and
protective processes in the central nervous system (CNS), including the regulation of neurotro-
phins and neuromediators, as well as anti-inflammatory, antiangiogenic and antioxidant effects
[3,4]. Consistently, vitamin D status has demonstrated links with brain health but also with eye
health and function [5-11]. Age-related lower serum 25-hydroxyvitamin D (25OHD) concen-
trations have been associated with worse visual acuity among older adults [7]. The reason for
this association is the purpose of much research. Parallel to the possibility of an involvement of
vitamin D in macular health [8], with vitamin D deficiency promoting age-related macular
degeneration (AMD) [9-13], other 'beyond-the-eye' explanations are also investigated. In par-
ticular, a previous work by our team has reported that vitamin D deficiency is associated with
smaller volume of optic chiasm in older adults [14], indicating possible loss of visual axons and
retinal ganglion cells associated with vitamin D deficiency. This assumption is consistent with
the neurosteroid effects of vitamin D reported in the CNS including in the optic nerve [3,4],
but also with the recent finding of an association between vitamin D deficiency and primary
open-angle glaucoma (POAG) [15]. Interestingly, POAG has been previously associated with
dementia [16,17], another condition in which vitamin D deficiency may play a role [6,18,19].
To date, it remains unclear whether vitamin D deficiency has an impact on the optic nerve
structure. Our purpose here was to determine in older adults whether vitamin D deficiency was
associated with reduced thickness of the ganglion cell complex (GCC) and of the retinal nerve
fibre layer (RNFL) measured with high-definition optical coherence tomography (HD-OCT).

**Material and Methods**

Participants

Between 30 November 2009 and 20 December 2012, 91 older community-dwellers were followed in the Memory Clinic of Angers University Hospital, France, for a subjective memory complaint, and were recruited into the Gait and Alzheimer Interactions Tracking (GAIT) study (ClinicalTrials.gov number, NCT01315717). The GAIT study is an observational cross-sectional study designed to examine gait in older community-dwellers reporting subjective memory complaint. The sampling and data collection procedures have been described elsewhere in detail [20]. In summary, subjective memory complaint was documented using the
Subjective Memory Complaints Questionnaire [21], and the main exclusion criteria were age below 60 years, Mini-Mental State Examination (MMSE) score <10 [22], inability to walk independently, history of stroke, history of any acute medical illness within the past 3 months, current delirium, severe depression, and inability to understand or answer the study questionnaires. For the present analysis, we only included patients without past or current ophthalmic conditions such as POAG or patent AMD. Thus, six participants who were diagnosed with previously unknown POAG were excluded from the study. Finally, 85 participants were included in this analysis.

In addition to a full medical examination and blood tests for vitamin D, calcium and albumin concentrations, all included participants underwent an ophthalmic evaluation, including best corrected visual acuity, pachymetry, standard automated perimetry (Program 30-2 of the Humphrey field analyzer, Carl Zeiss, Dublin, CA) with SITA-standard algorithm, fundoscopy, retinal fundus color imaging and HD-OCT.

## Dependent variables: GCC and RNFL thickness measurements with OCT

GCC and RNFL were determined automatically and analyzed using spectral-domain Cirrus HD-OCT model 4000 (software version 6.0; Carl Zeiss; Meditec, Dublin, CA). The pupil was not dilated. GCC thickness was isolated from a standard macular cube of 6 x 6 mm (512 x 128 scans), with global and sectoral measurements (i.e., superior nasal, superior medial, superior temporal, inferior nasal, inferior medial, inferior temporal). RNFL thickness was measured circularly at 3.4mm of the papillary center. Global and sectoral thickness measures (i.e., nasal, superior, temporal, inferior) were noted. Retinal segmentation was automatically performed by the program and immediately controlled by an experienced orthoptist who was blinded from participants' vitamin D status. Measurements were retried in case of misalignment. Arbitrarily, all measures were performed on the right eye of each participant, except for 2 participants with an epiretinal membrane in the right eye.

## Explanatory variable: Serum vitamin D deficiency

Venous blood was collected from resting participants. Serum 25OHD concentration, an effective indicator of vitamin D status [1,2], was measured by radioimmunoassay (DiaSorin corp., Stillwater, MN). Intra- and interassay precisions were respectively 5.2% and 11.3%. Vitamin D deficiency was defined *a priori* using the consensual 25OHD threshold of ≤25 nmol/L (to convert to ng/mL, divide by 2.496) i.e., deep and chronic hypovitaminosis D most likely to generate adverse health events [1,2,23]. All measurements were performed locally at the University Hospital of Angers, France.

## Covariables

The best corrected visual acuity was measured using decimal Monoyer charts and converted into logMAR units for statistical analysis purposes. After fundoscopy, images of the retinal fundus were systematically taken via non-mydriatic fundus photography and reexamined post-hoc by an experienced ophthalmologist. Evaluation of comorbidities (i.e., diseases lasting at least 3 months and running a course with minimal change, whatever the etiology) was based on self-report and medical record. All participants in the study had a cognitive assessment at the time of inclusion. Dementia was diagnosed using the consensus criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition [24]. Functional autonomy was assessed using the Instrumental Activities of Daily Living (IADL) score [25], with a score ranging from 0 to 4, best. The body mass index (BMI) was calculated as: $[weight (kg) / height^2]$
(m²)]. Weight was measured with a beam balance scale, and height with a height gauge. The intracranial volume, which was reported to possibly influence the OCT measures [26], was measured in cm³ to account for interindividual differences in the size of cranial cavity that could explain differences in intracranial su-volumes and thicknesses independent of vitamin D status. The intracranial volume was obtained from 3D T₁-weighted MP-RAGE images obtained from 1.5 Tesla MRI scanner (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany) (acquisition matrix = 256x256x144, FOV = 240mm x 240mm x 187mm, TE/TR/TI = 4.07ms/2170ms/1100ms) and analyzed using FreeSurfer (v5.1.0), a set of tools that automatically segments, labels and quantifies brain tissue volumes (http://surfer.nmr.mgh.harvard.edu/) [27]. The season of evaluation was recorded as follows: spring from March 21 to June 20, summer from June 21 to September 20, fall from September 21 to December 20, winter from December 21 to March 20. Finally, the serum concentration of calcium was measured using automated standard laboratory methods at the University Hospital of Angers, France. Because of the high prevalence of hypoalbuminemia in older adults, calcium values were corrected according to the formula: [corrected calcium value = $Ca + 0.02$ (46-albumin)].

Age, gender, BMI, number of comorbidities, dementia, IADL score, intracranial volume, visual acuity, serum calcium and season of testing were considered as potential confounders in our analysis.

## Statistical analysis

The participants' characteristics were summarized using means and standard deviations or frequencies and percentages, as appropriate. As the number of observations was higher than 40, no transform was applied [28]. Firstly, comparisons of participants' characteristics according to vitamin D status (i.e., deficiency of not) were performed using Student's t-test or the Chi-square test, as appropriate. Secondly, the mean difference of the GCC and RNFL thickness was calculated between participants with vitamin D deficiency and those with no vitamin D deficiency. Thirdly, multiple linear regressions were used to examine the associations of vitamin D deficiency (explanatory variable) with the GCC and RNFL thickness (dependent quantitative variables), while adjusting for potential confounders. Separate analyses were performed for this purpose. Finally, we examined the correlation between vitamin D deficiency and the thickness of the subregions of the GCC and RNFL. P-values <0.05 were considered significant. All statistics were performed using SPSS (v19.0; SPSS, Inc., Chicago, IL) and RevMan (v5.1, Nordic Cochrane Centre, Copenhagen, Denmark).

## Ethics

Participants participating in the study were included after having given their written informed consent for research. The study was conducted in accordance with the ethical standards set forth in the Helsinki Declaration (1983), and was approved by the University of Angers Ethical Review Committee (CPP Ouest II—2009-12).

## Results

Among 85 older participants with no patent ophthalmic disease who were included in this analysis (mean age, 71.1±4.7 years; 45.9% female; 100% Caucasian), the mean serum 25OHD concentration was 58.44±26.80 nmol/L. Eleven participants (12.9%) had vitamin D deficiency. The mean logMAR visual acuity was excellent, i.e. 0.03±0.06 and the mean visual field mean deviation was -1.25±2.29 dB (Table 1), with no difference between those with and those without vitamin D deficiency (P = 0.689 and P = 0.818, respectively). Overall, 82/85 patients had vision better than 20/25 in both eyes. Among the included patients, no cornea or other anterior
<table><caption>Table 1. Baseline characteristics of 85 participants by vitamin D status.</caption><thead><tr><th rowspan="2"></th><th rowspan="2">Total cohort (n = 85)</th><th colspan="2">Vitamin D deficiency*</th><th rowspan="2">P-value</th></tr><tr><th>Yes (n = 11)</th><th>No (n = 74)</th></tr></thead><tbody><tr><td><strong>Demographical measures</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Age, years</td><td>71.13±4.71</td><td>73.32±5.99</td><td>70.80±4.44</td><td>0.098</td></tr><tr><td>Female gender, n (%)</td><td>39 (45.9)</td><td>4 (36.4)</td><td>35 (47.3)</td><td>0.497</td></tr><tr><td><strong>Clinical measures</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Body mass index, kg/m<sup>2</sup></td><td>26.19±3.62</td><td>25.80±2.59</td><td>26.25±3.76</td><td>0.701</td></tr><tr><td>Number of comorbidities</td><td>2.28±1.78</td><td>2.64±0.92</td><td>2.23±1.88</td><td>0.484</td></tr><tr><td>Dementia, n (%)</td><td>5 (5.9)</td><td>0 (0.0)</td><td>5 (6.8)</td><td>0.374</td></tr><tr><td>IADL score, /4</td><td>3.76±0.53</td><td>3.64±0.67</td><td>3.78±0.50</td><td>0.390</td></tr><tr><td>Intracranial volume, cm<sup>3</sup></td><td>1517.65±170.27</td><td>1534.71±138.32</td><td>1515.07±175.57</td><td>0.764</td></tr><tr><td><strong>Ophthalmic findings</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Visual acuity, logMAR</td><td>0.03±0.06</td><td>0.02±0.04</td><td>0.03±0.06</td><td>0.689</td></tr><tr><td>Visual field mean deviation, dB</td><td>-1.25±2.29</td><td>-1.40±1.74</td><td>-1.22±2.37</td><td>0.818</td></tr><tr><td>Drusen detection, n (%)</td><td>10 (11.8)</td><td>0 (0.0)</td><td>10 (13.5)</td><td>0.194</td></tr><tr><td>Macular microcysts detection, n(%)</td><td>2 (2.4)</td><td>0 (0.0)</td><td>2 (2.7)</td><td>0.581</td></tr><tr><td>Mean macular thickness, µm</td><td>277.45±13.28</td><td>273.55±14.27</td><td>278.04±13.13</td><td>0.298</td></tr><tr><td>Mean GCC thickness, µm</td><td>76.77±7.64</td><td>72.09±7.44</td><td>77.48±7.46</td><td><strong>0.028</strong></td></tr><tr><td>Mean RNFL thickness, µm</td><td>89.35±12.21</td><td>84.18±16.07</td><td>90.12±11.47</td><td>0.133</td></tr><tr><td><strong>Serum measures</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>25-hydroxyvitamin D, nmol/L</td><td>58.44±26.80</td><td>19.00±3.77</td><td>64.30±23.56</td><td><strong>&lt;0.001</strong></td></tr><tr><td>Calcium, mmol/L</td><td>2.37±0.10</td><td>2.34±0.11</td><td>2.37±0.10</td><td>0.342</td></tr><tr><td><strong>Season</strong></td><td></td><td></td><td></td><td>0.619</td></tr><tr><td>Spring, n (%)</td><td>20 (23.5)</td><td>2 (18.2)</td><td>18 (24.3)</td><td></td></tr><tr><td>Summer, n (%)</td><td>16 (18.8)</td><td>1 (9.1)</td><td>15 (20.3)</td><td></td></tr><tr><td>Autumn, n (%)</td><td>47 (55.3)</td><td>8 (72.7)</td><td>39 (52.7)</td><td></td></tr><tr><td>Winter, n (%)</td><td>2 (2.4)</td><td>0 (0.0)</td><td>2 (2.7)</td><td></td></tr></tbody></table>

Data presented as mean±standard deviation when applicable. AMD: age-related macular degeneration; GCC: ganglion cell complex; IADL: Instrumental Activities of Daily Living; RNFL: retinal nerve fibre layer;

*: Serum 25-hydroxyvitamin D ≤ 25 nmol/L; P-values<0.05 indicated in bold.

doi:10.1371/journal.pone.0130879.t001

segment abnormalities were noted, except cataract, which was previously successfully operated in 13 of the included patients. Only 7 patients were diagnosed with mild cataract, with relatively preserved vision (higher than at least 20/50 on the right eye). Ten participants had asymptomatic macular drusen, but no patent AMD (P = 0.194 for between-group comparison). Only 2 participants had microcysts in the inner layer of the macula, with no between-group difference (P = 0.581). Similarly, there was no difference of macular thickness (P = 0.298). As indicated in Table 1, the participants with vitamin D deficiency had lower mean GCC thickness than those with 25OHD > 25nmol/L (72.09±7.44µm versus 77.48±7.46µm, P = 0.028). The mean difference in thickness was -5.39µm [95% confidence interval (CI): -10.10; -0.68] (Fig 1). In contrast, the RNFL thickness did not differ according to the vitamin D status (respectively 84.18±16.07µm versus 90.12±11.47µm, P = 0.133). There were no between-group differences for the other characteristics (Table 1). As illustrated in Table 2, fully adjusted linear regression showed a significant association of vitamin D deficiency with the mean GCC thickness (β = -5.12, P = 0.048), but not with the mean RNFL thickness (β = -9.98, P = 0.061).
HD-OCT measures (µm) Mean difference [95% CI]

<figure><img src="image_4.png" /><figcaption>**Fig 1.** Forest plot for the mean difference of ganglion cell complex (GCC) and retinal nerve fibre layer (RNFL) thickness according to vitamin D deficiency (i.e., serum 25-hydroxyvitamin D < 25 nmol/L). Horizontal lines correspond to the 95% confidence interval (CI). The vertical line corresponds to a mean difference of 0.00, equivalent to no between-group difference.</figcaption></figure>

doi:10.1371/journal.pone.0130879.g001

Table 3 reports the correlations between vitamin D deficiency and the thickness of the different sectors of the GCC and the RNFL. Vitamin D deficiency correlated negatively with the mean superior medial GCC (r = -0.26, P = 0.017) and superior temporal GCC (r = -0.28, P = 0.010), and there was a trend for a correlation with the superior nasal GCC (r = -0.21,

<table><caption>**Table 2.** Fully adjusted linear regressions examining the association between vitamin D deficiency* (explanatory variable) and the GCC and RNFL thickness† (dependent quantitative variables), adjusted for potential confounders (n = 85).</caption><caption>High-definition Optical Coherence Tomography</caption><thead><tr><th rowspan="2"></th><th colspan="3">GCC thickness</th><th colspan="3">RNFL thickness</th></tr><tr><th>β</th><th>[95% CI]</th><th>P-value</th><th>β</th><th>[95% CI]</th><th>P-value</th></tr></thead><tbody><tr><td>Vitamin D deficiency</td><td>-5.12</td><td>[-10.18;-0.06]</td><td><strong>0.048</strong></td><td>-9.98</td><td>[-20.46;-0.49]</td><td>0.061</td></tr><tr><td>Age</td><td>-0.58</td><td>[-1.03;-0.13]</td><td><strong>0.013</strong></td><td>-0.43</td><td>[-1.37;0.50]</td><td>0.356</td></tr><tr><td>Female gender</td><td>2.09</td><td>[-2.50;6.67]</td><td>0.365</td><td>1.37</td><td>[-8.08;10.82]</td><td>0.772</td></tr><tr><td>Body mass index</td><td>-0.51</td><td>[-1.01;0.00]</td><td>0.050</td><td>-0.24</td><td>[-1.29;0.80]</td><td>0.641</td></tr><tr><td>Number of comorbidities</td><td>-0.20</td><td>[-1.25;0.84]</td><td>0.696</td><td>-0.50</td><td>[-2.65;1.66]</td><td>0.645</td></tr><tr><td>Dementia</td><td>-4.95</td><td>[-13.11;3.21]</td><td>0.229</td><td>-8.99</td><td>[-25.88;7.90]</td><td>0.290</td></tr><tr><td>IADL score</td><td>-3.75</td><td>[-8.01;0.52]</td><td>0.084</td><td>-7.70</td><td>[-16.52;1.11]</td><td>0.085</td></tr><tr><td>Intracranial volume</td><td>0.00</td><td>[-0.01;0.01]</td><td>0.968</td><td>0.01</td><td>[-0.20;0.03]</td><td>0.592</td></tr><tr><td>Visual acuity</td><td>1.15</td><td>[-27.79;30.10]</td><td>0.998</td><td>-13.73</td><td>[-73.60;46.14]</td><td>0.647</td></tr><tr><td>Calcium</td><td>11.42</td><td>[-7.79;30.64]</td><td>0.238</td><td>-4.38</td><td>[-43.44;34.68]</td><td>0.823</td></tr><tr><td>Season</td><td>-0.87</td><td>[-3.02;1.28]</td><td>0.420</td><td>-1.26</td><td>[-5.63;3.11]</td><td>0.564</td></tr></tbody></table>

β: coefficient of regression corresponding to a change of thickness; CI: confidence interval; GCC: ganglion cell complex; IADL: Instrumental Activities of Daily Living; RNFL: retinal nerve fibre layer;

*: Serum 25-hydroxyvitamin D ≤ 25 nmol/L;

†: separate models used for each cognitive score; β significant (i.e., P-value<0.05) indicated in bold.

doi:10.1371/journal.pone.0130879.t002
<table><caption>Table 3. Correlation of vitamin D deficiency† with the thickness of the different sectors of the ganglion cell complex (GCC), and with the thickness of the different sectors of the retinal nerve fibre layer (RNFL).</caption><thead><tr><th></th><th>GCC</th><th>Superior nasal GCC</th><th>Superior medial GCC</th><th>Superior temporal GCC</th><th>Inferior nasal GCC</th><th>Inferior medial GCC</th><th>Inferior temporal GCC</th></tr></thead><tbody><tr><th scope="row">Vitamin D deficiency†</th><td>-0.24*</td><td>-0.21</td><td>-0.26*</td><td>-0.28**</td><td>-0.18</td><td>-0.18</td><td>-0.18</td></tr><tr><th></th><th>RNFL</th><th>Nasal RNFL</th><th>Superior RNFL</th><th>Temporal RNFL</th><th></th><th>Inferior RNFL</th><th></th></tr><tr><th scope="row">Vitamin D deficiency†</th><td>-0.16</td><td>-0.09</td><td>-0.09</td><td>-0.15</td><td></td><td>-0.18</td><td></td></tr></tbody></table>

*: P<0.05 (2-tailed);

**: P<0.01 (2-tailed);

***: P<0.001 (2-tailed);

†: Serum 25-hydroxyvitamin D ≤ 25 nmol/L

doi:10.1371/journal.pone.0130879.t003

P = 0.055). In contrast, vitamin D deficiency did not correlate with the inferior sectors of the GCC. Finally, there were no correlations between vitamin D deficiency and the different sectors of the RNFL (Table 3). Using serum 25OHD concentration as a quantitative variable, we found no significant correlation with neither the mean GCC thickness (r = 0.16, P = 0.142) nor the mean RNFL thickness (r = 0.15, P = 0.164).

Discussion

The main finding of this OCT study is that, irrespective of potential confounders, vitamin D deficiency was associated with reduced thickness of the mean GCC layer, and more specifically in its superior sectors. In contrast, there was no association between vitamin D deficiency and RNFL thickness.

To the best of our knowledge, this study is the first to assess and report such an association. This novel finding is consistent with recent literature reporting an association between vitamin D deficiency and structural abnormalities of the afferent visual pathways. In one prior study performed among 62 older adults (mean, 71.2±5.0 years; 45.2% female), vitamin D deficiency was associated with reduced macular thickness among older patients with no patent macular dysfunction (P = 0.001) [8]. Parallel, in another study, 20 independent community-dwelling older adults (mean, 74.3±6.3 years; 40.0% female) exhibited a direct association between serum 25OHD concentration and the volume of optic chiasm, with lower 25OHD relating to smaller optic chiasm [14]. The latter finding suggested the possibility of loss of the retinal ganglion cells and their axons associated vitamin D deficiency. Yet, only MRIs were performed in this latter study, and no detailed ophthalmologic evaluation was available. Thus, the results of the current study provide additional information. Specifically, we found that, in older adults without any known or clinically patent optic nerve condition, vitamin D deficiency was associated with GCC but not with RNFL thinning. Reduction of the macular retinal GCC, composed by the retinal ganglion cell layer and the inner plexiform layer, may be an early, initial manifestation of retinal ganglion cells loss. Indeed, the retinal ganglion cells are densest in the macula and form a stratified multi-cellular layer within the central area of the visual field. Loss of axons and/or retinal ganglion cell bodies in this region will result in thinning of the macular retinal ganglion cell layer, visible on HD-OCT. Thus, it has been suggested that thickness of the macula OCT and GCC complex could provide a better structural indicator of neuronal and/or axonal loss compared to the peripapillary RNFL scan in certain optic neuropathies [29]. Macular GCC measures may be better at detecting macular damage, while peripapillary RNFL measures would identify damage outside the macula [30]. Additionally, the high density of the
retinal ganglion cells in this region, and the lack of vessels, which can play a confounding role
in the peripapillary region, are important factors when measuring this region with OCT, as
compared to the peripapillary region.

The mechanism linking vitamin D deficiency with loss of retinal ganglion cells is not clearly
understood. Two approaches, which can be interconnected, are possible to explain such an
association: 1) vitamin D deficiency has direct, specific consequences on intraocular structures.
If the retinal ganglion cells were specifically susceptible to vitamin D deficiency, we would
expect that their loss could cause a patent neurodegenerative optic neuropathy, at least in some
severe, or longstanding cases. The neuronal loss in our study was probably affecting preferen-
tially the macular region, and thus possibly detected at an early stage, before thinning of the
RNFL and occurrence of a clinically patent optic neuropathy, such as POAG. Consistent with
this assumption is the lack of visual impairment in the case of vitamin D deficiency in our sam-
ple (Table 1), although such an association has previously been reported [7]. A similar situation
can be seen in other optic neuropathies, such as dominant optic atrophy, in which early retinal
ganglion cell loss occurs in the macular region [31,32], followed later by RNFL thinning. Inter-
estingly, vitamin D deficiency has been recently associated with POAG, a neurodegenerative
optic neuropathy, among 6094 participants recruited in the Fifth Korean National Health and
Nutrition Examination Survey [15]. Consistently, animal experimentation has reported that
vitamin D eye drops resulted in a reduction of intraocular pressure by 20% in non-human pri-
mates, mainly by increasing the uveoscleral outflow [33]. None of our patients had POAG or
high intraocular pressure, which were from the start necessary exclusion criteria, in order to
reduce potential confounders. However, we cannot rule out that some of the participants with
reduced GCC thickness and vitamin D deficiency in our study may subsequently evolve
towards a form of glaucoma, not necessary associated with high intraocular pressure. A pro-
spective follow-up of these groups of patients is currently ongoing at our institution. 2) A sec-
ond speculative approach is to consider that vitamin D deficiency is linked to generalized
neurodegeration, and that our original ophthalmic findings in asymptomatic patients would
represent a possibly early manifestation, or even biomarker of this global degeneration. The
tight interconnections between brain and retina have prompted several authors to consider the
retina as a privileged window to the brain, allowing early diagnosis and monitoring of neurode-
generative diseases [34]. As a related example, it is nowadays accepted that vitamin D defi-
ciency is associated with all-cause dementia and Alzheimer disease [18,19], conditions in
which retinal ganglion cell loss and RNFL thinning can be detected with OCT [35,36]. More
specifically, thinning of the macular retinal GCC was recently found in patients with Alzhei-
mer's disease (AD) [37]. Various neuroprotective effects of vitamin D in the CNS and the eye
may explain these associations. In vitro, vitamin D increases the synthesis of neurotrophic
agents such as the Nerve Growth Factor (NGF) and the Glial cell line-Derived Neurotrophic
Factor (GDNF), and regulates neuronal differenciation and maturation [3,4]. It also accelerates
neuronal growth in a dose-dependent way in rat hippocampal cell cultures [38]. Parallel, the
anti-inflammatory properties of vitamin D may be involved as there is evidence for a pivotal
role of vitamin D in the immune system [39,40] by modulating effect on the immune cells that
produce vitamin D and express the VDR. Finally, the antioxidant properties of vitamin D
against oxidative stress of reactive oxygen and nitrogen species in the central nervous system
[41] should also be mentioned.

The finding that vitamin D deficiency is associated with reduced GCC thickness has inter-
esting potential clinical implications. Indeed, even if there was no correlation in our study
between GCC thickness and serum 25OHD concentration used as a quantitative variable, it is
of note that providing a result in terms of linear correlation—in other words, reporting a
change in GCC thickness related to a change of 1 nmol/L of serum 25OHD—has only poor
significance for clinical practice compared to showing an association between vitamin D defi-
ciency and thinner GCC. To the best of our knowledge, there are no clear reference values for a
'clinically relevant change' in GCC thickness. In our study, we found a significant decrease of
5.39 µm (7.0%) in GCC thickness when comparing vitamin D sufficiency with vitamin D defi-
ciency (Fig 1). Such estimates may help to justify, plan, evaluate, and compare in the future the
effectiveness of interventions aiming at preventing optic neuropathy with vitamin D supple-
ments that would utilize change in GCC thickness as an outcome measure.

The strengths of our study include the originality of the research question on a highly common condition in older adults, the standardized collection of data from a single research center, and the detailed description of the participants' characteristics allowing the use of regression models to measure adjusted associations. Regardless, a number of limitations should be acknowledged. First, the study cohort was restricted to relatively healthy community-dwelling older participants who might be unrepresentative of the population of all seniors. Of note, our results are consistent with previous epidemiological cohorts since, beyond our main finding, we also reported that the GCC thickness depended on advancing age, which is consensual [42] and strengthens the relevance of our studied sample. Nevertheless, it is noticeable that lower 25OHD concentrations are also frequently encountered in children, adolescents and young adults [43]. Thus additional studies are needed to test the association between vitamin D deficiency and thickness of the optic pathways at the different stages of life. Second, the cohort was limited to 85 participants, which may have exposed to lack of statistical power. Third, although we excluded participants with POAG and patent AMD, a small proportion of participants with other ocular conditions, such as asymptomatic drusen, were still included. Fourth, at present, our study is cross-sectional, which limits conclusions regarding causality. Despite these limitations, we were able to show a 7-percent reduction in GCC thickness, but no reduced RNFL, with vitamin D deficiency among older adults with normal or subnormal vision. We propose that vitamin D deficiency may be associated at early stages with infraclinical, limited neuronal loss in the macular region, more easily detectable with spectral OCT. At later neurodegenerative stages, additional thinning of RNFL could in turn be detected. Further prospective studies are needed to clarify whether older adults with vitamin D deficiency are more likely to experience GCC and RNFL thinning than those with normal vitamin D status, and whether the correction of vitamin D deficiency could improve, or prevent, this process.

## Acknowledgments

The authors have listed everyone who contributed significantly to the work in the Acknowledg-
ments section. Permission has been obtained from all persons named in the Acknowledgments
section. Melinda Beaudenon, MS, Jennifer Gautier, BS, Romain Simon, MS, and Samuel Thi-
ery, BS, from Angers University Memory Clinic, France, for daily assistance. There was no
compensation for this contribution. Claire Rabaute and Marielle Chatreaux (orthoptists), Ste-
phanie Leruez, MD, Solene Coisy, MD, Angelique Caignard, MD, and Marion Verschorre,
MD, from the Department of Ophthalmology of Angers University Hospital, France, for daily
assistance. There was no compensation for this contribution.

Author Contributions

Conceived and designed the experiments: CA OB. Performed the experiments: MU MC AG
DM CA OB. Analyzed the data: MU CA. Contributed reagents/materials/analysis tools: MU
MC AG DM CA OB. Wrote the paper: MU MC AG DM CA OB.
References

1. Holick MF. (2007) Vitamin D deficiency. N Engl J Med 357: 266-281. PMID: 17634462

2. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. (2011) Vitamin D in the ederly: 5 points to remember. Geriatr Psychol Neuropsychiatr 9: 259-267. doi: 10.1684/pnv.2011.0288 PMID: 21896429

3. Kalueff AV, Tuohimaa P. (2007) Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 10: 12-19. PMID: 17143049

4. Annweiler C, Schott AM, Berrut G, Chauviré V, Le Gall D, Inzitari M, et al. (2010) Vitamin D and ageing: neurological issues. Neuropsychobiology 62: 139-150. doi: 10.1159/000318570 PMID: 20628264

5. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, et al. (2009) Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 16: 1083-1089. doi: 10.1111/j.1468-1331.2009.02755.x PMID: 19659751

6. Annweiler C, Dursun E, Féron F, Gezen-Ak D, Kalueff AV, Littlejohns T, et al. (2015) 'Vitamin D and cognition in older adults': updated international recommendations. J Intern Med 277: 45-57. doi: 10.1111/joim.12279 PMID: 24995480

7. Beauchet O, Milea D, Graffe A, Fantino B, Annweiler C. (2011) Association between serum 25-hydroxyvitamin D concentrations and vision: a cross-sectional population-based study of older adults. J Am Geriatr Soc 59: 568-570. doi: 10.1111/j.1532-5415.2010.03299.x PMID: 21391957

8. Graffe A, Beauchet O, Fantino B, Milea D, Annweiler C. (2014) Vitamin D and macular thickness in the elderly: an Optical Coherence Tomography study. Invest Ophthalmol Vis Sci 55: 5298-5303. doi: 10.1167/iovs.14-13918 PMID: 25028353

9. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. (2007) Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol 125: 661-669. PMID: 17502506

10. Graffe A, Milea D, Annweiler C, Beauchet O, Mauget-Faÿsse M, Beauchet O, et al. (2012) Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc 60: 1367-1069. doi: 10.1111/j.1532-5415.2012.04015.x PMID: 22788394

11. Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, et al. (2011) Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics 5: 538-568. PMID: 22155603

12. Seddon JM, Reynolds R, Shah HR, Rosner B. (2011) Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology 118:1386-1394. doi: 10.1016/j.ophtha.2010.12.020 PMID: 21620475

13. Annweiler C, Milea D, Beauchet O. (2012) Dietary vitamin D and AMD. Ophthalmology 119: 1090-1091 doi: 10.1016/j.ophtha.2012.02.005 PMID: 22551613

14. Annweiler C, Beauchet O, Bartha R, Graffe A, Milea D, Montero-Odasso M. (2013) Association between serum 25-hydroxyvitamin D concentration and optic chiasm volume. J Am Geriatr Soc 61: 1026-1028. doi: 10.1111/jgs.12249 PMID: 23772728

15. Yoo TK, Oh E1, Hong S. (2014) Is vitamin D status associated with open-angle glaucoma? A cross-sectional study from South Korea. Public Health Nutr 17: 833-843. doi: 10.1017/S1368980013003492 PMID: 24476947

16. Wostyn P, Audenaert K, De Deyn PP. (2009) Alzheimer's disease and glaucoma: is there a causal relationship? Br J Ophthalmol 93: 1557-1559. doi: 10.1136/bjo.2008.148064 PMID: 19286688

17. Kirby E, Bandelow S, Hogervorst E. (2010) Visual impairment in Alzheimer's disease: a critical review. J Alzheimers Dis 21: 15-34. doi: 10.3233/JAD-2010-080785 PMID: 20182034

18. Annweiler C, Llewellyn DJ, Beauchet O. (2013) Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 33: 659-674. doi: 10.3233/JAD-2012-121432 PMID: 23042216

19. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, et al. (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83: 920-928. doi: 10.1212/WNL.0000000000000755 PMID: 25098535

20. Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O. (2012) Vitamin D insufficiency and mild cognitive impairment: Cross-sectional association. Eur J Neurol 19; 1023-1029. doi: 10.1111/j.1468-1331.2012.03675.x PMID: 22339714

21. Vannier-Nitenberg C, Dauphinot V, Bongue B, Sass C, Rouch I, Beauchet O, et al. (2013) Early detection of memory impairment in people over 65 years old consulting at Health Examination Centers for
the French health insurance: the EVATEM protocol. BMC Geriatr 13: 55. doi: 10.1186/1471-2318-13-55 PMID: 23742705

22. Folstein MF, Folstein SE, McHugh PR. (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198. PMID: 1202204

23. Beauchet O, Hélard L, Montero-Odasso M, de Decker L, Berrut G, Annweiler C. (2012) Hypovitamino-sis D in geriatric inpatients: a marker of severity of chronic diseases. Aging Clin Exp Res 24: 188-192. doi: 10.3275/7838 PMID: 21737996

24. American Psychiatric Association. (1994) Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC.

25. Pérès K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. (2006) Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 67: 461-466. PMID: 16894108

26. Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N, et al. (2013) Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 70: 34-43. doi: 10.1001/jamaneurol.2013.573 PMID: 23318513

27. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341-355. PMID: 11832223

28. Rochon J, Gondan M, Kieser M. (2012) To test or not to test: Preliminary assessment of normality when comparing two independent samples. BMC Med Res Methodol 12: 81. doi: 10.1186/1471-2288-12-81 PMID: 22712852

29. Kardon RH. (2011) Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol 3: 353-361. doi: 10.1097/WNO.0b013e318238b9cb PMID: 22089499

30. Hood DC, Raza AS, de Moraes CG, Liebmann JM, Ritch R. (2013) Glaucomatous damage of the macula. Prog Retin Eye Res 32: 1-21. doi: 10.1016/j.preteyeres.2012.08.003 PMID: 22995953

31. Barboni P, Savini G, Cascavilla ML, Caporali L, Milesi J, Borrelli E, et al. (2014) Early Macular Retinal Ganglion Cell Loss in Dominant Optic Atrophy: Genotype-Phenotype Correlation. Am J Ophthalmol 158: 628-636.e3. doi: 10.1016/j.ajo.2014.05.034 PMID: 24907432

32. Rönnbäck C, Milea D, Larsen M. (2013) Imaging of the macula indicates early completion of structural deficit in autosomal-dominant optic atrophy. Ophthalmology 120: 2672-2677. doi: 10.1016/j.ophtha.2013.08.008 PMID: 24120325

33. Kutuzova GD, Gabelt BT, Kiland JA, Hennes-Beann EA, Kaufman PL, DeLuca HF. (2012) 1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys 518: 53-60. doi: 10.1016/j.abb.2011.10.022 PMID: 22198282

34. Jindal V. (2014) Interconnection Between Brain and Retinal Neurodegenerations. Mol Neurobiol [Epub ahead of print]

35. Larrosa JM, Garcia-Martin E, Bambo MP, Pinilla J, Polo V, Otin S, et al. (2014) Potential new diagnostic tool for Alzheimer's disease using a linear discriminant function for Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci 55: 3043-3051. doi: 10.1167/iovs.13-13629 PMID: 24736054

36. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 113: 523-526. doi: 10.1016/j.clineuro.2011.02.014 PMID: 21454010

37. Bayhan HA, Aslan Bayhan S, Celikbilek A, Tanik N, Gürdal C. (2014) Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography. Clin Experiment Ophthalmol [Epub ahead of print] doi: 10.1111/ceo.12386

38. Brown J, Bianco JI, McGrath JJ, Eyles DW. (2003) 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343: 139-143. PMID: 12759183

39. Lee V, Rekhi E, Kam JH, Jeffery G. (2012) Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging 33: 2382-2389. doi: 10.1016/j.neurobiolaging.2011.12.002 PMID: 22217419

40. Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, et al. (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182: 4624-4632. doi: 10.4049/jimmunol.0801543 PMID: 19342637

41. Ibi M, Sawada H, Nakanishi M, Kume T, Katsuki H, Kaneko S, et al. (2001) Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40: 761-771. PMID: 11369030
42. Sung MS, Kang BW, Kim HG, Heo H, Park SW. (2014) Clinical validity of macular ganglion cell complex by spectral domain-optical coherence tomography in advanced glaucoma. J Glaucoma 23: 341–346. doi: 10.1097/JG.0b013e318279c932 PMID: 23221905

43. Forrest KY, Stuhldreher WL. (2011) Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31: 48–54. doi: 10.1016/j.nutres.2010.12.001 PMID: 21310306